Biopharma Transcript

OrthoPediatrics Corp. KIDS

Nasdaq · EDGAR · Updated Nov 4, 2026

OrthoPediatrics Corp. (Nasdaq: KIDS) is a medical device company.

Upcoming catalysts

No catalyst is dated to the next 30 days or to an FDA action date.

Recent results and decisions

  1. Oct 27, 2026
    approval OrthoPediatrics received FDA clearance and subsequently launched PNP Retrograde.Continued to expand the portfolio with multiple new products, including FDA clearance and subsequent limited launch of PNP Retrograde. Filing

For subscribers